Gilead Sciences, Inc.
Human immunodeficiency virus neutralizing antibodies
Last updated:
Abstract:
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Status:
Grant
Type:
Utility
Filling date:
12 Feb 2019
Issue date:
5 Jan 2021